Atlas Trials

Rivaroxaban in Left Ventricular Thrombus

Clinical trial NCT04970576 · COMPLETED

Trial details

NCT number
NCT04970576
Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Coronary SyndromeLeft Ventricular Thrombus
Start date
2021-06-25
Primary completion
2024-05-31
Enrollment
261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.